Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Trading Indicators Flashing Green

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Dec 17, 2022 2:39pm

377 Views

Post# 35177792

RE:Trading Indicators Flashing Green

Many others have made bold predictions too. Everthing is lining up and maybe just maybe things will be different this time. Big thing is most are now in agreement that either a partnership or BO is imminent so that should help the sp. I am still hoping for a buyout and be done and am thinking that either a partnership or Bo offer could come in q1 and before bracelet results. The increased overall volume and slow steady price rise is very encouraging as it suggests that more and newer.buyers.are entering the onc market.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China